125: HALT: Targeted therapy beyond progression with or without dose-intensified radiotherapy in oligoprogressive disease in oncogene addicted lung tumours. (January 2017) - McDonald, F.; Guckenberger, M.; Popat, S.; Andratschke, N.; Kilburn, L.; Toms, C.; Bliss, J.